Have your own idea? Try our Stock Screener
Malaysian (KLSE) Pharma Industry Analysis
UpdatedJul 01, 2025
DataAggregated Company Financials
Companies6
- 7D3.4%
- 3M7.8%
- 1Y-8.7%
- YTD-1.7%
Over the last 7 days, the Pharma industry has risen 2.3%, driven by gains from Apex Healthcare Berhad of 7.0%. Meanwhile, Y.S.P. Southeast Asia Holding Berhad actually underperformed within the industry, shrinking 7.1% in the last week. However, the industry is down 9.1% over the past year. Earnings are forecast to grow by 11% annually.
Industry Valuation and Performance
Has the Malaysian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 01 Jul 2025 | RM 4.1b | RM 2.8b | RM 230.3m | 15.7x | 17.8x | 1.5x |
| Thu, 29 May 2025 | RM 4.0b | RM 2.8b | RM 230.3m | 15.9x | 17.5x | 1.4x |
| Sat, 26 Apr 2025 | RM 3.9b | RM 2.8b | RM 221.0m | 17x | 17.8x | 1.4x |
| Mon, 24 Mar 2025 | RM 3.7b | RM 963.6b | RM 76.7b | 13.5x | 0.05x | 0.004x |
| Wed, 19 Feb 2025 | RM 4.2b | RM 2.7b | RM 223.9m | 17.2x | 18.9x | 1.5x |
| Fri, 17 Jan 2025 | RM 4.0b | RM 2.7b | RM 223.9m | 16.3x | 18.1x | 1.5x |
| Sun, 15 Dec 2024 | RM 4.2b | RM 2.7b | RM 223.9m | 16.9x | 18.9x | 1.5x |
| Tue, 12 Nov 2024 | RM 4.3b | RM 2.7b | RM 236.6m | 14.7x | 18x | 1.6x |
| Thu, 10 Oct 2024 | RM 4.5b | RM 2.7b | RM 230.0m | 14.4x | 19.4x | 1.7x |
| Sat, 07 Sep 2024 | RM 4.3b | RM 2.7b | RM 230.0m | 14.4x | 18.5x | 1.6x |
| Mon, 05 Aug 2024 | RM 4.3b | RM 2.6b | RM 541.3m | 12.6x | 8x | 1.7x |
| Wed, 03 Jul 2024 | RM 4.5b | RM 2.6b | RM 541.3m | 13.1x | 8.3x | 1.7x |
| Fri, 31 May 2024 | RM 4.5b | RM 2.6b | RM 541.4m | 13.3x | 8.3x | 1.7x |
| Sun, 28 Apr 2024 | RM 4.8b | RM 2.6b | RM 559.3m | 12.5x | 8.5x | 1.8x |
| Tue, 26 Mar 2024 | RM 4.5b | RM 2.6b | RM 559.3m | 12.2x | 8.1x | 1.7x |
| Thu, 22 Feb 2024 | RM 4.6b | RM 2.6b | RM 585.2m | 12.2x | 7.9x | 1.8x |
| Sat, 20 Jan 2024 | RM 4.3b | RM 2.6b | RM 584.9m | 12.2x | 7.3x | 1.7x |
| Mon, 18 Dec 2023 | RM 4.2b | RM 2.6b | RM 584.9m | 12.2x | 7.2x | 1.6x |
| Wed, 15 Nov 2023 | RM 4.2b | RM 2.6b | RM 597.0m | 12.2x | 7.1x | 1.6x |
| Fri, 13 Oct 2023 | RM 4.3b | RM 2.6b | RM 604.4m | 12.2x | 7.1x | 1.7x |
| Sun, 10 Sep 2023 | RM 4.2b | RM 2.6b | RM 604.4m | 12.6x | 7x | 1.6x |
| Tue, 08 Aug 2023 | RM 4.4b | RM 2.6b | RM 304.7m | 13.9x | 14.6x | 1.7x |
| Thu, 06 Jul 2023 | RM 4.3b | RM 2.6b | RM 304.7m | 14.3x | 14.1x | 1.7x |
| Sat, 03 Jun 2023 | RM 4.6b | RM 2.6b | RM 304.7m | 14.7x | 15x | 1.8x |
| Mon, 01 May 2023 | RM 4.7b | RM 2.5b | RM 289.8m | 13.3x | 16.1x | 1.9x |
| Wed, 29 Mar 2023 | RM 4.7b | RM 2.5b | RM 289.8m | 13x | 16.2x | 1.9x |
| Fri, 24 Feb 2023 | RM 4.8b | RM 2.5b | RM 284.7m | 13.4x | 17x | 2x |
| Sun, 22 Jan 2023 | RM 4.7b | RM 2.4b | RM 270.7m | 13.1x | 17.2x | 1.9x |
| Tue, 20 Dec 2022 | RM 4.7b | RM 2.4b | RM 270.7m | 13.5x | 17.3x | 1.9x |
| Thu, 17 Nov 2022 | RM 4.2b | RM 2.4b | RM 248.4m | 12.5x | 17.1x | 1.8x |
| Sat, 15 Oct 2022 | RM 3.9b | RM 2.4b | RM 249.0m | 11.4x | 15.7x | 1.6x |
| Mon, 12 Sep 2022 | RM 3.9b | RM 2.4b | RM 249.0m | 11.9x | 15.8x | 1.6x |
| Wed, 10 Aug 2022 | RM 3.8b | RM 2.3b | RM 226.0m | 14x | 17x | 1.7x |
| Fri, 08 Jul 2022 | RM 3.5b | RM 2.3b | RM 226.0m | 13.9x | 15.7x | 1.5x |
Price to Earnings Ratio
15.7x
Current Industry PE
- Investors are optimistic on the Malaysian Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 17.8x which is higher than its 3-year average PE of 13.8x.
- The 3-year average PS ratio of 1.7x is higher than the industry's current PS ratio of 1.5x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 6.8% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Malaysian Healthcare industry?
| MY Market | 1.67% | |
| Healthcare | 0.048% | |
| Pharma | 3.41% | |
| Pharma | 3.41% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| AHEALTH Apex Healthcare Berhad | RM 2.28 | 7.0% +RM 108.1m | -19.4% | PE22.5x | |
| DPHARMA Duopharma Biotech Berhad | RM 1.34 | 2.3% +RM 28.9m | 7.2% | PE17.7x | |
| PLABS PeterLabs Holdings Berhad | RM 0.41 | 5.1% +RM 5.5m | 88.6% | PE40.2x | |
| KOTRA Kotra Industries Berhad | RM 4.19 | 0.2% +RM 1.5m | -1.2% | PE13.8x |